Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Spratt

Showing results (31-40 of 666) with videos related to

Pageof 67
Sort By:
Journal of Oral and Maxillofacial Surgery : Official Journal of the American Association of Oral and Maxillofacial Surgeons|January 1, 1982
Modification of the operating light by addition of a removable sterile drapeD R Moeller, E Spratt
Prostate Cancer and Prostatic Diseases|July 13, 2021
Drivers of racial disparities in prostate cancer trial enrollmentRandy Vince, Daniel E Spratt
Academic Medicine : Journal of the Association of American Medical Colleges|January 1, 2010
Locked-in: listening to save a lifeDaniel E Spratt, Michael Richardson
JAMA Oncology|December 19, 2024
Assessing the Risk of Radiation Myelitis in Hypofractionated Stereotactic Body Radiation Therapy-Tolerance Is in the Eye of the BeholderEvangelia Katsoulakis, Daniel E Spratt
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 22, 2016
Comparing Two Multifraction Spine Radiotherapy Regimens: Are They Really Equivalent?Daniel E Spratt, Nicholas Szerlip
International Journal of Radiation Oncology, Biology, Physics|February 25, 2026
Continuing the Focal FallacyJonathan Shoag, Daniel E Spratt
Cancer Research|December 15, 2019
RadioGx: A New Preclinical Tool to Model Intrinsic RadiosensitivityDaniel E Spratt, Corey Speers
International Journal of Radiation Oncology, Biology, Physics|May 11, 2020
Challenging the Norm: What Level of Evidence Is Necessary to Adopt Postprostatectomy Hypofractionated Radiation Therapy?Himanshu Nagar, Daniel E Spratt
The Lancet. Oncology|January 8, 2020
Androgen deprivation therapy plus salvage radiotherapy after prostatectomySamuel Birer, Daniel E Spratt
Brachytherapy|August 31, 2013
Point: There is a need for supplemental XRT with brachytherapy in the treatment of intermediate-risk prostate cancer patientsDaniel E Spratt, Michael J Zelefsky
Pageof 67

Showing results (31-40 of 666) with videos related to

Sort By:
Pageof 67
Journal of Oral and Maxillofacial Surgery : Official Journal of the American Association of Oral and Maxillofacial Surgeons|January 1, 1982
Modification of the operating light by addition of a removable sterile drapeD R Moeller, E Spratt
Prostate Cancer and Prostatic Diseases|July 13, 2021
Drivers of racial disparities in prostate cancer trial enrollmentRandy Vince, Daniel E Spratt
Academic Medicine : Journal of the Association of American Medical Colleges|January 1, 2010
Locked-in: listening to save a lifeDaniel E Spratt, Michael Richardson
JAMA Oncology|December 19, 2024
Assessing the Risk of Radiation Myelitis in Hypofractionated Stereotactic Body Radiation Therapy-Tolerance Is in the Eye of the BeholderEvangelia Katsoulakis, Daniel E Spratt
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 22, 2016
Comparing Two Multifraction Spine Radiotherapy Regimens: Are They Really Equivalent?Daniel E Spratt, Nicholas Szerlip
International Journal of Radiation Oncology, Biology, Physics|February 25, 2026
Continuing the Focal FallacyJonathan Shoag, Daniel E Spratt
Cancer Research|December 15, 2019
RadioGx: A New Preclinical Tool to Model Intrinsic RadiosensitivityDaniel E Spratt, Corey Speers
International Journal of Radiation Oncology, Biology, Physics|May 11, 2020
Challenging the Norm: What Level of Evidence Is Necessary to Adopt Postprostatectomy Hypofractionated Radiation Therapy?Himanshu Nagar, Daniel E Spratt
The Lancet. Oncology|January 8, 2020
Androgen deprivation therapy plus salvage radiotherapy after prostatectomySamuel Birer, Daniel E Spratt
Brachytherapy|August 31, 2013
Point: There is a need for supplemental XRT with brachytherapy in the treatment of intermediate-risk prostate cancer patientsDaniel E Spratt, Michael J Zelefsky
Pageof 67